Immobilization of heparin/poly-L-lysine nanoparticles on dopamine-coated surface to create a heparin density gradient for selective direction of platelet and vascular cells behavior

Acta Biomaterialia

Volumn 10, Issue 5, 2014, Pages 1940-1954

  Liu, Tao ^a   Liu, Yang ^a   Chen, Yuan ^a   Liu, Shihui ^a,b   Maitz, Manfred F ^a,c   Wang, Xue ^a   Zhang, Kun ^a   Wang, Jian ^a   Wang, Yuan ^a   Chen, Junying ^a   Huang, Nan ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

^b Beijing Naton Medical Group   (China)

^c LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

Author keywords

Blood compatibility; Endothelial cell; Heparin; Intimal hyperplasia; Nanoparticle

Indexed keywords

AMINES; CELL PROLIFERATION; DISEASES; ENDOTHELIAL CELLS; NEUROPHYSIOLOGY; PHASE LOCKED LOOPS; PLATELETS; POLYSACCHARIDES; STENTS;

BLOOD COMPATIBILITY; CELL BEHAVIOURS; COATED SURFACE; DENSITY GRADIENTS; DOPAMINE; ENDOTHELIAL-CELLS; IMMOBILISATION; INTIMAL HYPERPLASIA; POLY-L-LYSINE; VASCULAR CELLS;

NANOPARTICLES;

AMINE; ANTITHROMBIN III; DOPAMINE; FIBRINOGEN; HEPARIN; NANOPARTICLE; NITROGEN OXIDE; PADGEM PROTEIN; POLYLYSINE; 4',6 DIAMIDINO 2 PHENYLINDOLE; ANGIOTENSIN II; BIOMATERIAL; INDOLE DERIVATIVE; NITRIC OXIDE; RHODAMINE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CELL FUNCTION; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CHEMICAL COMPOSITION; CONTACT ANGLE; CONTROLLED STUDY; DENSITY GRADIENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FIBRIN FORMATION; HEMATOPOIETIC STEM CELL; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHILICITY; IMMOBILIZATION; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFRARED SPECTROSCOPY; LEUKOCYTE ADHERENCE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STATIC ELECTRICITY; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL; ANIMAL; ATOMIC FORCE MICROSCOPY; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MATERIALS TESTING; METABOLISM; SURFACE PROPERTY; ULTRASTRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL;

AMINES; ANGIOTENSIN II; ANIMALS; BLOOD PLATELETS; COATED MATERIALS, BIOCOMPATIBLE; DOPAMINE; ENDOTHELIAL CELLS; FIBRINOGEN; HEPARIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDOLES; MATERIALS TESTING; MICROSCOPY, ATOMIC FORCE; MYOCYTES, SMOOTH MUSCLE; NANOPARTICLES; NITRIC OXIDE; PARTICLE SIZE; PHOTOELECTRON SPECTROSCOPY; PLATELET ADHESIVENESS; POLYLYSINE; RATS; RHODAMINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; SURFACE PROPERTIES; WATER;

EID: 84898058377     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.12.013     Document Type: Article

References (55)

1. S. Windecker, and B. Meier Late coronary stent thrombosis Circulation 116 17 2007 1952 1965
2. R.A. Byrne, J. Mehilli, and R. Iijima A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents Eur Heart J 30 8 2009 923 931
3. G.C. Li, P. Yang, W. Qin, M.F. Maitz, S. Zhou, and N. Huang The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization Biomaterials 32 2011 4691 4703
4. Z.L. Yang, J. Wang, R.F. Luo, M.F. Maitz, F.J. Jing, and H. Sun et al. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility Biomaterials 31 8 2010 2072 2083
5. F.R. Guo, X.Y. Cheng, S.F. Wang, Y.C. Zhao, Y. Gao, and H.B. Cai Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents Acta biomater 6 2 2010 534 546
6. I. Bjork, and U. Lindahl Mechanism of the anticoagulant action of heparin Mol Cell Biochem 48 3 1982 161 182
7. N. Cindhuchao, D.A. Quinn, H.G. Garg, and C.A. Hales Heparin inhibits SMC growth in the presence of human and fetal bovine serum Biochem Biophys Res Commun 302 1 2003 84 88
8. R.A. Hoshi, R. Van Lith, M.C. Jen, J.B. Allen, K.A. Lapidos, and G. Ameer The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts Biomaterials 34 1 2013 30 41
9. J.R. Guyton, R.D. Rosenberg, A.W. Clowes, and M.J. Karnovsky Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin Circ Res 46 5 1980 625 634
10. Y.K. Ahn, M.H. Jeong, J.W. Kim, S.H. Kim, J.H. Cho, and J.G. Cho et al. Preventive effects of the heparin-coated stent on restenosis in the porcine model Catheter Cardiovasc Interv 48 3 1999 324 330
11. P.W. Serruys, B. van Hout, H. Bonnier, V. Legrand, E. Garcia, and C. Macaya et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet 352 9129 1998 673 681
12. J.P. Boyle, R.H. Smart, and J.K. Shirey Heparin in the treatment of chronic obstructive bronchopulmonary disease Am J Cardiol 14 1964 25 28
13. N.L. Fine, C. Shim, and M.H. Williams Objective evaluation of heparin in the treatment of asthma Am Rev Respir Dis 98 1968 886 887
14. H.E. Conrad Heparin-binding proteins 1998 Academic Press New York, London
15. J. Yu, A.J. Wang, Z.Y. Tang, J. Henry, B.L.P. Lee, and Y.Q. Zhu et al. The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration Biomaterials 33 32 2012 8062 8074
16. R. Cariou, J.L. Harousseau, and G. Tobelem Inhibition of human endothelial cell proliferation by heparin and steroids Cell Biol Int Rep 12 12 1988 1037 1047
17. A.A. Khorana, A. Sahni, O.D. Altland, and C.W. Francis Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight Arterioscler Thromb Vasc Biol 23 11 2003 2110 2115
18. Z.L. Yang, Q.F. Tu, J. Wang, and N. Huang The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization Biomaterials 33 28 2012 6615 6625
19. S.E. Sakiyama-Elbert Incorporation of heparin into biomaterials Acta Biomater 10 4 2013 1581 1587
20. X.H. Wang, D.P. Li, W.J. Wang, Q.L. Feng, F.Z. Cui, and Y.X. Xu et al. Covalent immobilization of chitosan and heparin on PLGA surface Int J Biol Macromol 33 1-3 2003 95 100
21. S. Liu, T. Liu, J. Chen, M. Maitz, C. Chen, and N. Huang Influence of a layer-by-layer-assembled multilayer of anti-CD34 antibody, vascular endothelial growth factor, and heparin on the endothelialization and anticoagulation of titanium surface J Biomed Mater Res A 101 4 2013 1144 1157
22. J. Lee, J.J. Yoo, A. Atala, and S.J. Lee Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity Acta Biomater 8 7 2012 2549 2558
23. F. Zhang, M. Fath, R. Marks, and R.J. Linhardt A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies Anal Biochem 304 2 2002 271 273
24. H. Chen, Y. Chen, H. Sheardown, and M.A. Brook Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer Biomaterials 26 2005 7418e24
25. W.B. Tsai, W.T. Chen, H.W. Chien, W.H. Kuo, and M.J. Wang Poly(dopamine) coating of scaffolds for articular cartilage tissue engineering Acta Biomater 7 12 2011 4187 4194
26. B. Joddar, A. Albayrak, J. Kang, M. Nishihara, H. Abe, and Y. Ito Sustained delivery of siRNA from dopamine-coated stainless steel surfaces Acta Biomater 9 5 2013 6753 6761
27. Z.L. Yang, Q.F. Tu, Y. Zhu, R.F. Luo, X. Li, and Y.C. Xie et al. Mussel-inspired coating of polydopamine directs endothelial and smooth muscle cell fate for re-endothelialization of vascular devices Adv Healthc Mater 1 5 2012 548 559
28. 2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents Biomaterials 32 5 2011 1253 1263
29. J.S. Park, K. Park, D.G. Woo, H.N. Yang, H.M. Chung, and K.H. Park Triple constructs consisting of nanoparticles and microspheres for bone-marrow-derived stromal-cell-delivery microscaffolds Small 4 11 2008 1950 1955
30. T. Merdan, J. Kopecek, and T. Kissel Prospects for cationic polymers in gene and oligonucleotide therapy against cancer Adv Drug Deliv Rev 54 5 2002 715 758
31. P.K. Smith, A.K. Mallia, and G.T. Hermanson Colorimetric method for the assay of heparin content in immobilized heparin preparations Anal Biochem 109 2 1980 466 473
32. P. Hamerli, T. Weigel, T. Groth, and D. Paul Surface properties of and cell adhesion onto allylamine-plasma-coated polyethylenterephtalat membranes Biomaterials 24 22 2003 3989 3999
33. Q.L. Li, N. Huang, C. Chen, J.L. Chen, K.Q. Xiong, and J.Y. Chen et al. Oriented immobilization of anti-CD34 antibody on titanium surface for self-endothelialization induction J Biomed Mater Res A 94 2010 1283 1293
34. 2 J Eur Ceram Soc 32 1 2012 235 244
35. E. Monchaux, and P. Vermette Effects of surface properties and bioactivation of biomaterials on endothelial cells Front Biosci (Schol Ed) 2 2010 239 255
36. R. Hattori, K.K. Hamilton, R.D. Fugate, R.P. McEver, and P.J. Sims Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140 J Biol Chem 264 14 1989 7768 7771
37. S.T. Olson, and I. Bjork Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects J Biol Chem 26 1991 6353 6364
38. S.T. Olson, I. Bjork, R. Sheffer, P.A. Craig, J.D. Shore, and J. Choay Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement J Biol Chem 267 1992 12528 12538
39. S. Moncada Nitric oxide in the vasculature: physiology and pathophysiology Ann N Y Acad Sci 811 1997 60 67 (discussion: 67-9)
40. T. Thum, D. Tsikas, S. Stein, M. Schultheiss, M. Eigenthaler, and S.D. Anker et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine J Am Coll Cardiol 46 2005 1693 1701
41. Červinka P, Bystroň M, Špaček R, Kvašňák M, Jakabčin J. Randomized Comparison of Genous Stent Versus Chromium-Cobalt stent for Treatment of ST-Elevation Myocardial Infarction. 6-month Clinical, Angiographic and IVUS Follow-up. GENIUS-STEMI trial. Presented at the American College of Cardiology Annual Scientific Session 2009.
42. H. Lee, S.M. Dellatore, W.M. Miller, and P.B. Messersmith Mussel-inspired surface chemistry for multifunctional coatings Science 318 2007 426 430
43. H. Lee, J. Rho, and P.B. Messersmith Facile conjugation of biomolecules onto surfaces via Mussel adhesive protein inspired coatings Adv Mater 21 4 2009 431 434
44. Y.K. Joung, S.S. You, K.M. Park, D.H. Go, and K.D. Park In situ forming, metal-adhesive heparin hydrogel surfaces for blood-compatible coating Colloids Surf B Biointerfaces 99 2012 102 107
45. Y.S. Jung, J.H. Jeong, S. Yook, B.H. Im, J. Seo, and S.W. Hong et al. Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model Biomaterials 33 1 2012 295 303
46. J. Dai, S. Zou, Y. Pei, D. Cheng, H. Ai, and X. Shuai Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery Biomaterials 32 6 2011 1694 1705
47. D. Zhou, C. Li, Y. Hu, H. Zhou, J. Chen, and Z. Zhang et al. Glycopolymer modification on physicochemical and biological properties of poly(l-lysine) for gene delivery Int J Biol Macromol 50 4 2012 965 973
48. M. Yamagata, T. Kawano, K. Shiba, T. Mori, Y. Katayama, and T. Niidome Structural advantage of dendritic poly(l-lysine) for gene delivery into cells Bioorg Med Chem 15 1 2007 526 532
49. T.S. Lakshmi, N. Shanmugasundaram, S. Shanmuganathan, K. Karthikeyan, J. Meenakshi, and M. Babu Controlled release of 2, 3 desulfated heparin exerts its anti-inflammatory activity by effectively inhibiting E-selectin J Biomed Mater Res A 95 1 2010 118 128
50. W.J. Gomes, and E. Buffolo Coronary stenting and inflammation: implications for further surgical and medical treatment Ann Thorac Surg 81 5 2006 1918 1925
51. C. Haery, R. Sachar, and S.G. Ellis Drug-eluting stents: the beginning of the end of restenosis? Cleve Clin J Med 71 10 2004 815 824
52. R. Rossini, M. Baroni, G. Musumeci, and A. Gavazzi Oral antiplatelet therapy after drug-eluting stent implantation: adherence and side-effects J Cardiovasc Med (Hagerstown) 14 2 2013 81 90
53. S. Verheye, P. Agostoni, K.D. Dawkins, J. Dens, W. Rutsch, and D. Carrie et al. The GENESIS (randomized, multicenter study of the pimecrolimus-eluting and pimecrolimus/paclitaxel-eluting coronary stent system in patients with de novo lesions of the native coronary arteries) trial JACC Cardiovasc Interv 2 3 2009 205 214
54. T. Adriaenssens, J. Mehilli, R. Wessely, G. Ndrepepa, M. Seyfarth, and A. Wieczorek et al. Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial J Am Coll Cardiol 49 12 2007 1265 1271
55. R. Wessely New drug-eluting stent concepts Nat Rev Cardiol 7 4 2010 194 203